TY  - GEN
AU  - Yuan,Yong
AU  - Trivedi,Digisha
AU  - Maclean,Ross
AU  - Rosenblatt,Lisa
TI  - Indirect cost-effectiveness analyses of abatacept and rituximab in patients with moderate-to-severe rheumatoid arthritis in the United States
SN  - 1941-837X
PY  - 2011///0428
KW  - Abatacept
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - economics
KW  - Antirheumatic Agents
KW  - Cost-Benefit Analysis
KW  - Disability Evaluation
KW  - Female
KW  - Health Status Indicators
KW  - Humans
KW  - Immunoconjugates
KW  - Immunologic Factors
KW  - Methotrexate
KW  - Middle Aged
KW  - Monte Carlo Method
KW  - Quality-Adjusted Life Years
KW  - Rheumatic Fever
KW  - drug therapy
KW  - Rituximab
KW  - Severity of Illness Index
KW  - Surveys and Questionnaires
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
KW  - United States
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3111/13696990903508021
ER  -